Exchange: NASDAQ·Updated 07:52 PM EDT
News
all
press releases
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWD
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWD $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWD PR Newswire NEW YORK, July 29, 2026 NEW YORK, July 29, 2026 /PRNewswire...
PR Newswire
More News
Are FNWD, PSNL, DSGR Obtaining Fair Deals for their Shareholders?
Are FNWD, PSNL, DSGR Obtaining Fair Deals for their Shareholders? Are FNWD, PSNL, DSGR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 27, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring
Tempus AI acquires Personalis for $1.5B to target the $20B MRD cancer monitoring market. Get full deal details and analysis.read more...
Benzinga
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders?
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 21, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...
PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Personalis, Inc. (NASDAQ: PSNL)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Personalis, Inc. (NASDAQ: PSNL) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Personalis, Inc. (NASDAQ: PSNL) PR Newswire NEW YORK, July 21, 2026 NEW YORK, July 21, 2026 /PRNewswire/ -- Class...
PR Newswire
Tempus AI acquires cancer-monitoring firm Personalis for $1.5 billion
Tempus AI acquires cancer-monitoring firm Personalis for $1.5 billion...
Yahoo! Finance: News
Tempus AI acquires Personalis in $1.5bn precision oncology-focused deal
Tempus AI acquires Personalis in $1.5bn precision oncology-focused deal...
Yahoo! Finance: News
TEM, PSNL Stocks Are Falling — Why Morgan Stanley Still Likes Tempus AI’s Personalis Deal
The brokerage said the acquisition strengthens Tempus AI’s precision oncology business, though near-term financials are less compelling.
Stocktwits
PSNL Stock Alert: Halper Sadeh LLC is Investigating Whether Personalis, Inc. is Obtaining a Fair Price for Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Personalis, Inc. (NASDAQ: PSNL) to Tempus AI, Inc. for $16.25 per share of common stock. The consideration is reported to be structured as a 100% stock transaction, with Tempus having the option to elect payment in cash at...
Business Wire
Tempus AI Slides as Investors Weigh $1.5 Billion Personalis Acquisition
Tempus AI stock falls after a $1.5 billion Personalis deal expands its reach in the $20 billion MRD market.read more...
Benzinga
<
1
2
>

Advertisement|Remove ads.